Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

Digital Power Corp. (DPW) Addressing Demanding Market Applications with High-Grade Power System Solutions

Digital Power designs, develops, manufactures and sells high-grade customized and off-the-shelf power system solutions for the most demanding applications in the medical, military, telecom and industrial markets. In July, the company unveiled its newest family of products, which features a … Continue reading

Posted in Small Cap News | Leave a comment

Erin Energy Corp. (ERN) Building Shareholder Value through Exploration and Development of Assets in Sub-Saharan Africa

Erin Energy is an independent oil and gas exploration and production company focused on energy resources in sub-Saharan Africa. The company’s asset portfolio includes nine licenses across four countries covering an area of approximately 16,600 square miles, including current production … Continue reading

Posted in Small Cap News | Leave a comment

Skyline Medical, Inc. (SKLN) (SKLNU) Providing a Safer Approach to Surgical Waste Handling with Innovative STREAMWAY® System

Skyline Medical, Inc. (NASDAQ: SKLN, SKLNU) is a medical device company engaged in the production and commercialization of an innovative, environmentally-friendly tool targeted at improving the safety of one of the most dangerous jobs in the medical field. The company’s … Continue reading

Posted in Small Cap News | Leave a comment

Catalyst Pharmaceuticals, Inc. (CPRX) Rapidly Approaching Commercialization of Firdapse®

Catalyst Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies for people with rare debilitating diseases. The company’s lead product candidate, Firdapse®, recently completed a pivotal phase III clinical trial for the treatment of Lambert-Eaton … Continue reading

Posted in Small Cap News | Leave a comment

International Stem Cell Corp. (ISCO): A Double Threat with Cutting-Edge, Ethically Derived Stem Cell Therapies & Commercial-Scale Biobanking

On the cusp of milestone TGA (Therapeutic Goods Administration) authorization in Australia to start clinical trials in its breakthrough Parkinson’s disease (PD) treatment using human parthenogenetic neural stem cells (hpNSCs), International Stem Cell Corp. (OTCQB: ISCO) was proud to show … Continue reading

Posted in International Stem Cell Corp. ISCO | Leave a comment

ENGlobal Corp. (ENG) Expands Management Team

ENGlobal, a leading provider of automation and engineering services, announced this morning that it has added two key professionals to its management team in newly created positions. The decision to expand its leadership team was made to support the company’s … Continue reading

Posted in ENGlobal Corp. ENG | Leave a comment

ENGlobal Corp. (ENG) Demonstrates Versatility with Profitable Second Quarter Results

In the second quarter of 2015, ENGlobal Corp. (NASDAQ: ENG) recorded its sixth straight quarter of profitable results. In large part, these results were attributable to the consistent performance of the company’s engineering and construction segment, which accounted for over … Continue reading

Posted in ENGlobal Corp. ENG | Leave a comment

RestorGenex Corp. (RESX) Looks to Address Underserved Oncology Indications with Innovative Product Candidate

RestorGenex Corp. (OTCQX: RESX) is a specialty biopharmaceutical company focused on the development of a portfolio of first-in-class therapeutic products to treat diseases across the oncologic, ophthalmologic and dermatologic space. The company’s lead product candidate, RES-529, is a novel PI3K/Akt/mTOR … Continue reading

Posted in Small Cap News | Leave a comment

International Stem Cell Corp. (ISCOD) Leading the Way in Emerging Field of Regenerative Medicine with Parthenogenetic Stem Cell Technology

International Stem Cell Corporation is a biotechnology company utilizing a proprietary new stem cell technology known as parthenogenesis to significantly advance the field of regenerative medicine. The company’s innovative technology uses unfertilized human eggs to create human pluripotent stem cells … Continue reading

Posted in International Stem Cell Corp. ISCO | Leave a comment

Arotech Corp. (ARTX) Announces $6.7 Million Production Contract

Earlier today, Arotech reported a $6.7 task order from the Space and Naval Warfare Center (SPAWAR) Atlantic. The contract came through its North American Power System Division, which includes UEC Electronics. The contract awarded is for the manufacture and integration … Continue reading

Posted in Small Cap News | Leave a comment